What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

The Christie NHS Foundation Trust

Home
United Kingdom
Manchester
The Christie NHS Foundation Trust

Please note this account is only monitored 9am – 5pm Monday to Friday (not Bank Holidays). To cont These services help increase income for our NHS developments.

The Christie is one of Europe’s leading cancer centres, treating more than 44,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester and Cheshire, but as a national specialist around 26% patients are referred to us from other parts of the country. Our annual turnover is £173 million and we have 2,500 staff, 350 volunteers and 18,000 public members. NHS services
We provide:
• radiotherapy through one of the largest radiotherapy departments in the world, both on our main site in south Manchester and via The Christie radiotherapy centre in Oldham
• chemotherapy in the largest chemotherapy unit in the UK and via 14 other hospitals
• highly specialist surgery for complex and rare cancer
• a wide range of support and diagnostic services

Research & Education
We are also an international leader in research, with world first breakthroughs for over 100 years. Our clinical trials unit is the largest early phase trials unit in the world, with around 200 trials ongoing at any one time. We are part of the Manchester Cancer Research Centre with The University of Manchester and Cancer Research UK and also one of seven partners in the Manchester Academic Health Science Research Centre. Cancer research in Manchester has been officially ranked the best in the UK. The Christie School of Oncology provides undergraduate education, clinical professional and medical education and is the first of its kind in the UK. Joint ventures
We provide private patient services through The Christie Clinic, our joint venture with HCA International. Developments
Our developments are breaking new ground and transforming treatment and care for cancer patients. These include a unique network of Christie radiotherapy centres in other parts of the area to deliver treatment closer to people’s homes and the development of our young oncology services in partnership with the Teenage Cancer Trust. History
We have achieved world firsts since The Christie was established in 1901. It was named The Christie in recognition of the pioneering work of both Richard Copley Christie and his wife Mary Ellen Christie. At this time there were 30 beds and 463 patients a year. Charity
Our charity is the second largest hospital charity in the country. Over 2,000 fundraisers and 20,000 supporters help bring in £15.9 million a year, which helps fund additional patient services and vital research. To find ‘The Christie charity’ on facebook please follow this link

29/03/2026

"Instead of thinking of what I can’t do, I focus on what I can do and what I love to do, which is rather a lot as it turns out!”

Rachel Woodruff from Holmes Chapel has been living with blood cancer for 14 years.

Rachel, who recently celebrated her 89th birthday, has a full and active life. She enjoys going out with friends and has been learning the ukulele for a year.

Rachel also loves tennis. She represented Cheshire in the 'over 75s' category and played regularly up until last year. She is now just seeing how it goes.

Rachel went to her GP back in 2012 as she had a pain in her back that wouldn’t go away. After several tests and scans, she was diagnosed with myeloma and was referred to The Christie at Macclesfield where she has been treated ever since.

Rachel has had six different types of treatment over the years and is currently looking into clinical trials.

“Advances in cancer treatment have meant that I’ve been able to get so much out of the last 14 years of my life,” she says. “I've got a large family and, although I’m not as active as I once was, I still love spending time outdoors,” she says.

“It’s so important to have a positive attitude about things – that’s really helped me get the most out of life."

27/03/2026

A pioneering dementia nurse consultant who has spent more than half a century caring for patients in the NHS is retiring at the end of March 💙

Lorraine Burgess is stepping down from her role as lead dementia nurse consultant at The Christie after a remarkable 51-year career in healthcare, including 14 years helping transform support for cancer patients living with dementia.

Lorraine was the UK’s first Macmillan dementia nurse consultant in a specialist cancer centre.

She worked closely with patients, families and clinical teams to ensure people living with both cancer and dementia receive the right care and support throughout their treatment.

Her work has made a real difference to patients and their loved ones. One family said:
“Lorraine sorted everything I needed to help me get Mum through the surgery and to recover afterwards.”

In 2014 Lorraine was named Nurse of the Year at the prestigious Nursing Times Awards. She met Prince Charles in 2020, and also gained the title of Queen’s Nurse whilst at The Christie.

Lorraine has shaped dementia-friendly care across The Christie, supporting staff and improving services for some of our most vulnerable patients.

We thank Lorraine for everything she has given to patients, families and colleagues, and wish her a very happy retirement 🌼

25/03/2026

You can now access MyChristie, our online patient portal, using your NHS app login details.

Existing login details aren’t affected by this, and you can still register on our website. Using your NHS app login details is just another way to access the portal.

Patients can use MyChristie to check most upcoming appointments, view clinical letters, and update their care teams using health questionnaires.

It’s part of Future Christie, our 10-year transformation programme designed to make care more personal, joined-up and efficient, while keeping the same compassionate touch that The Christie is known for.

23/03/2026

“I was able to walk my daughter Holly down the aisle just six weeks after having my treatment, which was amazing, Tex says. “Nearly six years on, I’m still doing really well.”

Tex Leece, a 52-year-old father of two from Bolton, is still cancer-free after being treated for oropharyngeal (throat) cancer at The Christie

Tex received standard intensity-modulated radiotherapy (IMRT) as part of a trial that compared the effectiveness of this treatment with proton beam therapy for oropharyngeal cancer. The results, which have now been published, show that both options are just as effective as each other.

“I was able to walk my daughter Holly down the aisle just six weeks after having my treatment, which was amazing, Tex says. “Nearly six years on, I’m still doing really well and am very active.”

Professor David Thomson, Consultant Clinical Oncologist at The Christie and Chief Investigator of the TORPEdO trial, comments:

“Long-term outcomes with IMRT were very good and matched proton beam therapy. We are extremely grateful to the patients and multidisciplinary teams who made this trial possible.

“IMRT is widely available and delivers excellent outcomes for patients. Proton beam therapy also plays an important role in cancer care. The treatment is standard of care for several groups, including children and young adults, and select other adult indications. Ongoing research continues to improve our understanding."

20/03/2026

“Meeting such interesting people – patients I’ll remember forever – is the reason why this role remains appealing after all these years.”

Jane Booker has worked at The Christie for over 40 years, making her one of our longest-serving clinical nurse specialists.

Jane works alongside surgical and clinical oncology teams to support people with urological cancers such as prostate, pe**le and bladder cancer. She's there for patients and families from the point of diagnosis and beyond.

Jane has helped introduce several innovations that are now part of everyday practice.

She piloted The Christie’s first telephone follow-up service in 1999, reducing the need for hospital visits for routine checks, and later developed the first nurse-led clinics for prostate and bladder cancer in the early 2000s.

"The rise of the input of specialist nurses has allowed for greater numbers of patients to be treated holistically,” she explains. “We are often the face of The Christie for patients, in terms of being their first port of call if they have queries or concerns about what is happening to them as they go through treatment. Every day is different, even when the rota looks the same."

Together,

18/03/2026

A retired nurse from Oldham is benefiting from a faster way of receiving her cancer treatment.

Rosemary Andrew was diagnosed with renal cell cancer - a form of kidney cancer - in June 2022. After surgery, she is now receiving the immunotherapy drug nivolumab as a quick under-the-skin injection rather than through a drip into a vein.

The change means her treatment visit now takes around 10 minutes. She has it at one of our local centres - Dr Kershaw's Hospice in Royton.

Rosemary said: “It takes around 20 minutes compared with a two-hour trip to The Christie in Withington. It means less time sitting in a clinical setting and more time getting on with normal life.”

Her most recent scan in January 2026 showed no measurable disease.

“When I was first diagnosed, my prognosis was bleak, so to be here now and living my life means everything,” Rosemary said.

Less time spent in treatment means she has more time for the things she enjoys – like volunteering at the Age UK charity shop in Oldham, reading, watching football, and being with her family. 💙

16/03/2026

Today is National Cancer Clinical Nurse Specialist (CNS) Day.🎉

CNSs are senior nurses who provide patients with specialist support right from the point of diagnosis.

Narinder Saini, Deputy Chief Nurse, says:

"We have over 130 clinical nurse specialists at The Christie supporting patients and families at every stage of their cancer treatment. Today is a chance to recognise and thank them all for the difference they make every day."

Thank you to all our CNSs for everything you do.💙

14/03/2026

“I want to give people hope that they can achieve anything they put their mind to, even amidst life’s toughest challenges.”

Asia Sharif, an award-winning software engineer from Manchester, is preparing to celebrate her first anniversary of being free from blood cancer after multiple rounds of demanding treatment at The Christie.

27-year-old Asia finally went into remission after having a stem cell transplant last year.

After spending the last two years at The Christie, experiencing the uncertainty that comes with a cancer diagnosis, Asia is sharing her story to inspire others. She’s giving a TED talk later in the year that will cover her cancer journey and her successful career in engineering and social impact.

“I am incredibly excited for the next chapter of my life. There are so many announcements and projects on the horizon, and I can’t wait to continue this journey.

“I truly believe I was placed on this earth to do more, to make a difference, and to inspire the next generation. Every challenge I’ve faced has strengthened my purpose and my drive to give back," she adds.

13/03/2026

Want to find out more about the plans for our new CT scanning centre?

Join the team from our charity on Tuesday 24 March, 10.30am–12pm to hear about the new purpose-built scanning centre they're helping to fund.

You’ll hear from Prof Jon Bell and Dr Pavan Najran on how the centre and new technology, including a 4D CT scanner, could transform care.

Patient speaker Justine Carson will also speak about her treatment at The Christie.

📆 Tuesday 24 March
🕝 10.30am-12.30pm
📍 Oglesby Cancer Research Building, Palatine Road

Find out more and reserve your place 👇

12/03/2026

“I wasn’t sure what to expect when they reduced the dose, but my life has been transformed. My energy levels are higher, and I can socialise as normal."

80-year-old Jonathan is one of the first men with prostate cancer to trial a lower dose of hormone-blocking drugs ahead of a larger trial that is opening this month.

The ENHANCE trial, which will be led by Christie researchers, will evaluate whether reducing the dose of hormone therapies such as abiraterone and enzalutamide can provide patients with the same life-extending benefits while reducing side effects.

Diagnosed with prostate cancer at the end of 2024, Jonathan struggled badly with the side effects of the hormone-blocking drug enzalutamide - he felt constantly tired, had hot flushes, and felt weak.

When his nurse reduced his dose, his cancer remained under control and his quality of life improved dramatically.

"The difference soon became apparent, and I felt normal again. I now exercise more and do not usually need an afternoon sleep. Happily, my PSA level started to go down until, after a few months, it was undetectable and has, so far remained undetectable," he says

“I’m delighted that this trial has the potential to help others going through the same thing in the future by enabling them to be treated for prostate cancer with their quality of life still largely intact.”

The ENHANCE study will recruit 1,500 men from hospitals across the UK. Crucially, at least 10% of participants will be Black men – a group that has historically been underrepresented by research. The £3.2m study is being funded by Cancer Research UK and Prostate Cancer UK

10/03/2026

It’s Healthcare Science Week, a chance to celebrate the people behind the everyday innovation and cancer care here at The Christie.

Healthcare scientists play a vital role in bringing new technology safely into clinical practice.

Clinical engineer Megan Davies is exploring how 3D printing and digital design can help personalise radiotherapy for patients by creating bespoke devices such as:

➡️ Brachytherapy applicators - devices that help place radiotherapy exactly where it’s needed in the body
➡️ Wax bolus moulds - shaped materials that ensure the right dose reaches the skin
➡️ Mouth stents -devices that position the mouth to protect healthy tissue during radiotherapy treatment

Together, these personalised devices help make radiotherapy more precise, more consistent and more comfortable for patients.

Her work shows how curiosity about doing something better and teamwork can lead to real improvements in patient care.

“Curiosity drives our work,” says Megan. “We’re asking how we can make radiotherapy more precise or more comfortable for patients by using digital design and 3D printing.

Healthcare science brings ideas into real clinical practice, safely and carefully, so patients benefit.”

You can read more about Megan in the latest issue of our magazine. 👇

08/03/2026

On International Women's Day, we're celebrating the contributions of all the brilliant women who work at The Christie.

We asked three of our colleagues what advice they'd give to their younger selves. Here's what they had to say. 👇

⚛️ Dr Heather Williams heads up our medical physics and engineering department, one of only a few women in the country to have that role. She says: “Keep going, keep growing – you are stronger than you know.”

⭐ Alveena Malik is one of our non-executive directors. She says: “You stand on the shoulders of some remarkable women. Carry forward their dignity, resilience and kindness. Let those strengths help you become the leader they always believed you could be.”

💙Laura O'Shea is a senior allied health professional. She says: “Never lose sight of where you came from — your roots and your values will take you further than any qualification ever will.”

Address

550 Wilmslow Road
Manchester
M204BX

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Telephone

+441614463000

Website

http://www.christie.nhs.uk/

Alerts

Be the first to know and let us send you an email when The Christie NHS Foundation Trust posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to The Christie NHS Foundation Trust:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Want your practice to be the top-listed Clinic in Manchester?

Our Story

The Christie is one of Europe’s leading cancer centres, treating more than 44,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester and Cheshire, but as a national specialist around 26% patients are referred to us from other parts of the country. Our annual turnover is £173 million and we have 2,500 staff, 350 volunteers and 18,000 public members. NHS services We provide: • radiotherapy through one of the largest radiotherapy departments in the world, both on our main site in south Manchester and via The Christie radiotherapy centre in Oldham • chemotherapy in the largest chemotherapy unit in the UK and via 14 other hospitals • highly specialist surgery for complex and rare cancer • a wide range of support and diagnostic services Research & Education We are also an international leader in research, with world first breakthroughs for over 100 years. Our clinical trials unit is the largest early phase trials unit in the world, with around 200 trials ongoing at any one time. We are part of the Manchester Cancer Research Centre with The University of Manchester and Cancer Research UK and also one of seven partners in the Manchester Academic Health Science Research Centre. Cancer research in Manchester has been officially ranked the best in the UK. The Christie School of Oncology provides undergraduate education, clinical professional and medical education and is the first of its kind in the UK. Joint ventures We provide private patient services through The Christie Clinic, our joint venture with HCA International. These services help increase income for our NHS developments. Developments Our developments are breaking new ground and transforming treatment and care for cancer patients. These include a unique network of Christie radiotherapy centres in other parts of the area to deliver treatment closer to people’s homes and the development of our young oncology services in partnership with the Teenage Cancer Trust. History We have achieved world firsts since The Christie was established in 1901. It was named The Christie in recognition of the pioneering work of both Richard Copley Christie and his wife Mary Ellen Christie. At this time there were 30 beds and 463 patients a year. Charity Our charity is the second largest hospital charity in the country. Over 2,000 fundraisers and 20,000 supporters help bring in £15.9 million a year, which helps fund additional patient services and vital research. To find ‘The Christie charity’ on facebook please follow this link